“Modifiable Hyperkalemia with Timely Recognition”- Beta Blocker (Metoprolol succinate) induced

Prasad, Prasanth and Raj, Sumesh (2022) “Modifiable Hyperkalemia with Timely Recognition”- Beta Blocker (Metoprolol succinate) induced. Asian Journal of Research in Medical and Pharmaceutical Sciences, 11 (3). pp. 12-14. ISSN 2457-0745

[thumbnail of 193-Article Text-370-2-10-20220919.pdf] Text
193-Article Text-370-2-10-20220919.pdf - Published Version

Download (254kB)

Abstract

This case report describes the very rarest possibility of drug induced hyperkalemia with beta blockers. In literature search only 2 cases were reported as metoprolol succinate induced hyperkalemia in diabetes patients without renal insufficiency. As per FDA reports only 0.5 % patients have reported hyperkalemia induced by metoprolol [1]. Patient is diabetic and hypertensive. And she is on oral hypoglycemic agents, premixed insulin and on beta blockers along with calcium channel blocker. The potassium value was ranging from 6 to 6.7 mmol/l. Evaluated in detail and no other abnormalities noted in laboratory investigations. Once the offending drug metoprolol is withdrawn the potassium value reaches to normal range in very short period.

Item Type: Article
Subjects: Oalibrary Press > Medical Science
Depositing User: Managing Editor
Date Deposited: 16 Feb 2023 07:46
Last Modified: 26 Jul 2024 06:25
URI: http://asian.go4publish.com/id/eprint/1247

Actions (login required)

View Item
View Item